Shopping Cart
Remove All
Your shopping cart is currently empty
NOS-IN-2 (Compound 4i), an imidamide-derived NOS inhibitor, exhibits high potency and selectivity, specifically inhibiting iNOS with an IC50 of 20 μM while sparing eNOS. Demonstrating minimal toxicity, it is suitable for research on inflammatory disorders [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $1,980 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $2,500 | 10-14 weeks | 10-14 weeks |
| Description | NOS-IN-2 (Compound 4i), an imidamide-derived NOS inhibitor, exhibits high potency and selectivity, specifically inhibiting iNOS with an IC50 of 20 μM while sparing eNOS. Demonstrating minimal toxicity, it is suitable for research on inflammatory disorders [1]. |
| Targets&IC50 | nNOS:>1000 μM, iNOS:20 μM |
| In vitro | NOS-IN-2 (Compound 4i) exhibits high iNOS selectivity with no eNOS inhibition activity [1] and demonstrates minimal toxicity (0-100 μM, 30 min) [1]. In a Cell Viability Assay using HUVECs, little toxicity was observed except at concentrations above 100 μM, where cell viability was significantly reduced by approximately 20% [1]. |
| In vivo | NOS-IN-2 (Compound 4i) is anticipated to exhibit oral bioavailability [1]. |
| Molecular Weight | 367.37 |
| Formula | C18H20F3N3O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.